ClinConnect ClinConnect Logo
Search / Trial NCT06984133

Structured Education Program and Glycemic Control in Adolescents With Type 1 Diabetes

Launched by DASMAN DIABETES INSTITUTE · May 14, 2025

Trial Information

Current as of July 09, 2025

Recruiting

Keywords

Kuwait Glycemic Control Type 1 Diabetes Carbohydrate Counting Arab Adolescents Structured Education Adolescents Diabetes Education Program Hb A1c

ClinConnect Summary

This clinical trial is looking at how a structured education program can help Arab adolescents aged 11 to 14 manage their type 1 diabetes better. Type 1 diabetes is a condition where the body doesn’t produce insulin, which is needed to control blood sugar levels. Many young people with this condition struggle to keep their blood sugar in a healthy range, leading to complications and affecting their daily lives. In this study, some participants will receive a special educational program designed to improve their understanding of diabetes management, while others will continue with regular care for comparison.

To be eligible for the trial, participants must be Arab adolescents who have been diagnosed with type 1 diabetes for at least six months and are using a continuous glucose monitor (CGM). They should also be able to participate fully in the study with their parents. Participants will take part in assessments, including measuring their growth and blood sugar control, and will fill out questionnaires about their health and lifestyle. Those in the education group will attend a four-day program, including a day for parents, and will keep a food diary during this time. After six months, the control group will also have the chance to join the program. This trial aims to see if education can make a real difference in managing diabetes for these young individuals.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Arab adolescents
  • Males and females aged 11 to 14 years.
  • Have been diagnosed with type 1 diabetes for at least 6 months.
  • Wearing a continuous glucose monitor (CGM).
  • Individuals and their parents must be able to join the entire duration of the study.
  • Individuals and their parents must voluntarily provide consent and assent.
  • Exclusion Criteria:
  • Presence of learning disabilities or any known psychological issues.
  • Attendance at any diabetes education or carbohydrate counting programs within the six months preceding the study.

About Dasman Diabetes Institute

Dasman Diabetes Institute (DDI) is a leading research and clinical organization dedicated to advancing diabetes care and management through innovative research, education, and community outreach. Established to address the growing prevalence of diabetes, DDI focuses on conducting high-quality clinical trials aimed at developing effective prevention and treatment strategies. The institute collaborates with local and international partners to enhance understanding of diabetes and its complications, fostering a multidisciplinary approach that integrates clinical practice with cutting-edge research. With a commitment to improving patient outcomes, DDI serves as a vital resource for healthcare professionals, researchers, and individuals affected by diabetes.

Locations

Kuwait City, Sharq, Kuwait

Patients applied

0 patients applied

Trial Officials

Ebaa Al Ozairi, MD

Study Director

Dasman Diabetes Institute

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported